| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-07 |
| mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-07 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-07 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
1e-06 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |